leisure time -WSS

leisure time

author：Wikipedia 2025-08-19 18:04:39 - browse：2

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： What we owe ALS patients — and why one company fell short

WSS

Ascension's ugly legal battle over care for poor patients in Texas

Nonprofit, backed by Microsoft, to certify AI tools in health care

What we owe ALS patients — and why one company fell short

6 solutions to address cancer drug shortages and others

Study suggests new cause of Down syndrome: cells linked to aging

2023 Nobel Prize in Medicine goes to Karikó and Weissman

knowledge

leisure time

explore

Supreme Court strikes down use of affirmative action

Some top drug companies are starting to take action on climate

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

RSV injection headlines need to be accurate for good uptake

Bright Health sells Medicare Advantage business to Molina

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Sports medicine is finally prioritizing gender equality

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Apple is now the first public company to be valued at $3 trillion

CRISPR base editing slashes cholesterol levels in monkeys

hotspot

What will Novo Nordisk's VC do with its influx of cash?

Medicare Advantage overpayments discussion gets experts fired up

The biotech scorecard for Q4: 16 stock

Lawsuit highlights wrinkle for disputes over surprise medical bills

JPM pitch from hospitals? Revenue streams outside of patient care

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

focus

focus

knowledge

Wikipedia